Background: Demodex mites are permanent ectoparasites of human pilosebaceous unit. They mainly infect skin of the face and scalp. Many studies have shown higher density of the ectoparasites in diseased inflammatory skin than in normal skin. The aim of this study was to determine the frequency of Demodex folliculorum (DF) in treatment-resistant patients with the combination of allergic rhinitis (AR) and diabetes mellitus (DM). Method: This study was conducted in 2014-2017. It included 92 patients aged 18-70 years who presented at the Ear, Nose and Throat (ENT) and Endocrinology Polyclinics of Mustafa Kemal University Medical Faculty Hospital, Turkey. An age and gender matched control group was formed of 30 healthy individuals. To determine the presence of DF, a few eyelashes were taken from eyelids in both groups. Then samples were examined under a light microscope. Results: DF positivity was determined in 44 (47.8%) of the 92 patients and in 1 (3.3%) of the 30 control group subjects. In the patient group, DF positivity was evaluated as present in 14 (43.7%) of the DM patients, in 12 (40%) of the AR patients and in 18 (60%) of the AR+DM patients. Statistically significant DF incidence was found in all three patient groups compared to the control group (P=0.001). The incidence in AR + DM group was not different from other patient groups. Conclusion: DM, AR, advanced age and obesity had prepared the environment for Demodex infestations. This issue should be considered especially in treatment of patients with AR+DM.
ÖZET Amaç: Bu çalışmada Mustafa Kemal Üniversitesi öğrencilerinin mobil sağlık uygulamalarını kullanım sıklığının belirlenmesi amaçlanmıştır. Gereç ve Yöntem: Kesitsel tanımlayıcı tipteki bu çalışma, Mustafa Kemal Üniversitesi öğrencileriyle Aralık 2017-Şubat 2018 tarihlerinde yürütülmüştür. Çalışmaya katılmayı kabul eden farklı fakülte ve yüksekokullardan 877 öğrenci çalışmaya dâhil edildi. Çalışmada uygulanan anket literatürde yer alan mobil sağlık teknolojileri ile ilgili çalışmalardan yararlanılarak hazırlanmıştır. Bulgular: Çalışmaya 877 kişi katıldı. Yaş ortancaları 21 (en küçük:17 en büyük:36) idi. %51'i erkek (n=447) %49'u kadın (n=430) idi. Katılımcıların %90,6 (n=795)'sı sosyal medya kullanmaktaydı. Katılımcılardan sosyal medyada yer alan sağlık ile ilgili paylaşımları takip edenlerin oranı %51,8 (n=454) idi. Sağlıkla ilgili uygulamaları kullananlar %34,2 (n=300) idi. Katılımcıların %11,5'i (n=101) mobil sağlık uygulamalarını her gün kullanmaktayken, %4,3'ü (n=38) mobil sağlık uygulamalarını ayda bir kullanmaktaydı. Sonuç: Bireylerin tablet ve akıllı telefon kullanımlarının artması ile mobil sağlık uygulamalarının da kullanımı artabilir. Böylelikle bireylerin yaşam tarzlarının, diyetlerinin ve egzersizlerinin düzenlenmesine katkı sağlanabilir. Yaşam tarzı değişikliği önerilen hastaların mobil sağlık uygulamalarını kullanması tedavi uyumlarını arttıracağı düşünülmektedir. ABSTRACTObjective: In this study it is aimed to determine the prevalence of how university students mobile health applications usage. Methods: This cross-sectional descriptive study was carried out with Mustafa Kemal University students between December 2017 and February 2018. Eight hundred seventy seven students from different faculties and higher schools who agreed to participate in the study were included in the study. The questionnaire applied in the study was prepared considering the studies related to the mobile health technologies in the literature. Results: Eight hundred seventy seven individuals participated in the study. The median age was 21 (min: 17 max: 36). 51% of the participants were male (n = 447) and 49% were female (n = 430). 90.6% (n = 795) of participants were using social media. 51.8% (n = 454) of the participants followed the health-related sharing in the social media. 34.2% (n = 300) were using health related practices. While 11.5% (n = 101) of participants were using mobile health applications every day, 4.3% (n = 38) were using monthly. Conclusion: The increased use of tablets and smartphones by individuals may also increase the use of mobile healthcare applications. This can contribute to the regulation of individuals' lifestyles, diets and exercises. It is thought that frequent use of mobile health practices by "patients who are offered lifestyle modification" will increase treatment compliance.
Objective: Sickle Cell Disease (SCD) patients experience recurrent pain attacks and up to 30% of these become chronic pain. There is known to be a relationship between chronic pain and depression and other psychological problems. Therefore, Sickle Cell Disease patients often experience a series of social and psychiatric problems. The aim of this study to determine the frequency and severity of premenstrual syndrome in women aged ≥18 years with sickle cell disease and to compare these values with healthy women. Methods: This case control study was conducted from January 2018 to March 2018. The data were collected using a questionnaire of 21 items and the Premenstrual Syndrome Scale (PMSS). Statistical analysis was performed using SPSS 21 software. Results: The study included 50 patients aged with 18 years who were diagnosed sickle cell anemia at the University Hospital and control group of 50 subjects have no chronic disease. Premenstrual Syndrome (PMS) according to DSM-5 was determined in 34 (68%) of the case group and 39 (78%) of the control group (p=0,26). Mean depressive effect subscale score was 15.64±6.56 in the sickle cell anemia group while, it was 19.48±6.67 in control group (p=0,05). Conclusions: Although PMS frequency and symptom severity in women with SCD were similar with normal population, the depressive effect subscale scores were lower in SCD group. This results' cause could be attributed to PMS symptoms being perceived as less severe compared to the pain experienced in sickle cell crises.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.